People with bipolar disorder face stigma and treatment challenges. Despite these barriers, it's possible to live a full and ...

CIII allows people who have tried at least two oral antidepressants to use the spray on its own – without the need for more ...

The U.S. Food and Drug Administration (FDA) approved the antidepressant nasal spray Spravato as a standalone treatment for depression in adults.

Medicare beneficiaries may pay less for 15 additional prescription drugs as early as 2027 as part of the next round of federal regulators' price negotiations with pharmaceutical manufacturers.

Professional support groups and networks play a vital role in addressing challenges faced by those living with bipolar ...

Celebrities who have opened up about their bipolar diagnosis remind us that no matter how privileged a life may seem, ...

Medicare has chosen 15 prescription medications for price negotiations this year, building off a first round of negotiations ...

Ozempic and Wegovy, the blockbuster but costly GLP-1 drugs often used for weight loss, are among the 15 medications that will ...

He adds: “Even when a person isn’t actively symptomatic, they will always have a non-zero risk of experiencing another episode of depression or mania.” “The mainstays of treatment for bipolar disorder ...

J&J will pay $132 a share, the company said in a statement. That's 39% above the closing price Friday. Bloomberg earlier reported a deal was in the works. Shares of Intra-Cellular rose 36% to $128.72 ...

As a psychiatrist, I have two options for treating my patients: mood stabilizers, which are usually anticonvulsants, and antipsychotics. Antipsychotics are a key treatment in managing bipolar I ...

The authors note that larger clinical trials — looking at factors such as baseline depression severity and treatment duration — are needed to back up these results. Key Takeaway NAC may help treat ...